Bruker DRX 400 NMR spectrometer [(1H) 400 MHz, CHCl3
δ 7.27; and (13C) 100 MHz, CHCl3 δC 77.2]. J-Values are in
Hz. GLC analyses were performed with a DBwax column
(J&W Scientific) capillary column (30 m; 0.25 mm i.d., 0.25
µm stationary phase). Mps were measured on a Gallenkamp
melting point apparatus and are uncorrected.
57.4, 55.9 (2 C), 38.3, 35.8 and 19.2 (2 C); HRMS (CI-CH4):
C9H21O4 (M ϩ H); Found: m/z, 193.1447. Calc.: m/z, 193.1440.
(2R,3S,5R)- and (2R,3S,5S)-1,3,5-Trimethoxyheptan-2-ol 4
and 5 (entries 7–12, 15). The general procedure was applied
to compound 1 and the ethyl-group donors shown in Table 1.
Column chromatography (E/H 1:10 → 1:1) of the crude
product gave an inseparable mixture of products 4/5 as a syrup:
ν(film)/cmϪ1 3440; δH 3.87 and 3.72 (each 1 H, 2 m), 3.54 (8 H,
m), 3.41, 3.39, 3.38, 3.33, 3.32 and 3.32 (each 3 H, 6 s), 2.57
(each 1 H, 2 s), 1.76 (4 H, m), 1.55 (4 H, m) and 0.88 and 0.87
(6 H, 2 t, J 7.5); δC 79.0, 78.8, 78.4, 77.8, 73.5, 71.5, 71.3, 59.2,
59.1, 58.3, 57.2, 56.2, 56.1, 35.0, 32.2, 25.8, 25.4, 8.9 and 8.7;
HRMS (CI-CH4): C10H23O4 (M ϩ H); Found: m/z, 207.1600.
Calc.: m/z, 207.1596.
(2R,3S,5R)- and (2R,3S,5S)-1,3,5-Trimethoxy-5-phenyl-
pentan-2-ol 6 and 7 (entry 13). The general procedure was
applied to compound 1 and ZnPh2. Column chromatography
(E/H 1:10 → 1:1) of the crude product gave an inseparable
mixture of products 5/6 as a syrup: ν(film)/cmϪ1 3420 and 3100;
δH 7.32 (each 5 H, 2 m), 4.39 and 4.33 (each 1 H, 2 dd), 3.88 and
3.82 and 7.32 (each 1 H, 2 m), 3.50 (6 H, m), 3.47, 3.40, 3.39,
3.33, 3.21 and 3.23 (each 3 H, 6 s), 2.63 (each 1 H, 2 s) and 2.18,
1.88, 1.84 and 1.75 (each 1 H, 4 m); δC 142.6, 142.0, 128.7 (2 C),
128.6 (2 C), 127.9, 127.7, 126.8 (2 C), 126.6 (2 C), 80.3, 80.0,
79.0, 78.7, 74.0, 73.6, 71.8, 71.3, 59.4, 59.3, 58.8, 57.4, 56.7,
56.6, 40.21 and 37.3; HRMS (CI-CH4): C14H23O4 (M ϩ H);
Found: m/z, 255.1595. Calc.: m/z, 255.1597.
(2R,4S,5R)- and (2S,4S,5R)-5-Hydroxy-2,4,6-trimethoxy-
hexanonitrile 8 and 9 (entry 14). The general procedure was
applied to compound 1 and Me3SiCN. Column chrom-
atography (E/H 1:10 → 1:1) of the crude product gave an
inseparable mixture of products 8/9 as a syrup: ν(film)/cmϪ1
3460 and 2064; δH 4.32 and 4.28 (each 1 H, 2 dd), 3.86 and 3.85
(each 1 H, 2 m), 3.50 (6 H, m), 3.515, 3.505, 3.42, 3.41, 3.405
and 3.40 (each 3 H, 6 s), 2.50 and 2.40 (each 1 H, 2 d) and 2.17
and 2.05 (each 2 H, 2 m); δC 118.6, 118.3, 78.8, 77.0, 73.3, 73.2,
70.9, 70.8, 68.1, 67.2, 59.4 (2 C), 58.7, 58.3 (2 C), 58.1, 34.7 and
33.8; HRMS (CI-CH4): C9H18NO4 (M ϩ H); Found: m/z,
204.1236. Calc.: m/z, 204.1236.
IR, mass and optical rotation data were recorded with a
Nicolet Impact 410 Infrared Spectrometer, a JEOL JMS-SX
102 mass spectrometer and a Perkin-Elmer 241 Polarimeter,
respectively. All reactions were carried out in oven-dried flasks
or vials equipped with rubber septa and under an argon atmos-
phere. The organometallic reagents were transferred by dried,
argon-flushed syringes and cannulas. Heptane was distilled
from sodium. CH2Cl2 was distilled from CaH2 and stored over
molecular sieves. Ethyl acetate was distilled immediately before
use. TiCl4 and Ti(OPri)4 were purchased from Aldrich and
Janssen respectively, and diluted with dry CH2Cl2 to 2.0
before use. ZnMe2 (2.0 in toluene; Merck), ZnEt2 (1.0 in
hexane; Merck), ZnPh2 (Alfa), AlMe3 (2.0 in hexane;
Aldrich), AlEt3 (1.0 in hexane; Merck) and Me3SiCN (Fluka
AG) were all used without further purification. MeTiCl3,
Cl3Ti(OPri)45 and the substrates 1056 and 1357 were prepared
according to the respective literature procedure.
Methyl 2-deoxy-3,5-di-O-methyl-â-D-erythro-pentofuranoside
and its á-D-anomer á/â-1
A solution of ‘2-deoxy--ribose’ (5.0 g, 37.6 mmol) in 0.05%
HCl/MeOH (190 ml) was stirred at room temp. for 30 min,
followed by addition of Ag2CO3 (1.0 g, 3.6 mmol). The result-
ing solution was stirred for 5 min and was then filtered, evapor-
ated and finally co-evaporated with THF (3 × 10 ml), to afford
6.4 g of an oily mixture of the anomeric methyl glycosides. This
mixture was dissolved in THF (85 ml) and the solution was
cooled to 0 ЊC. NaH (60%; 3.3 g, 83 mmol) and MeI (11 g,
5.2 ml, 83 mmol) were alternately added in portions as the
temperature was slowly raised to ambient. The resulting
slurry was stirred for 60 h, whereafter MeOH (4 ml) was
added and the suspension was poured into ice–water (100 ml).
CH2Cl2 (100 ml) was now added and the aqueous phase was
extracted with CH2Cl2 (3 × 35 ml). The combined extracts
were washed with water (2 × 100 ml), dried (MgSO4), and
concentrated in vacuo. Column chromatography (E/H
3:7 → 2:3 → 1:1) afforded the β- (1.6 g, 24%) and α-
anomer (2.4 g, 36%) of compound 1. Spectral data were as
reported in the literature.58
(2R,3R,4S,5R)- and (2R,3R,4S,5S)-1,3,4,5-Tetramethoxy-
hexan-2-ol 11 and 12 (entries 16 and 17). The general procedure
was applied to compound 10 and the methyl-group donors
shown in Table 1. Column chromatography (E/H 1:10 →
1:1) of the crude product gave compounds 11 and 12 as syrups
(H/E 1:2).
Compound 11: Rf 0.40; [α]2D0 ϩ24 (c 2.57, CHCl3); ν(film)/cmϪ1
3430; δH 3.89 (1 H, m), 3.55 (3 H, m), 3.47, 3.42, 3.41 and 3.35
(each 3 H, 4 s), 3.35 (2 H, m), 3.27 (1 H, d, J 3.5) and 1.21 (3 H,
d, J 6.3); δC 84.0, 80.7, 76.9, 74.0, 71.0, 59.8, 59.6, 59.3, 56.7
and 15.0; HRMS (CI-CH4): C10H23O5 (M ϩ H); Found: m/z,
223.1544. Calc.: m/z, 223.1546.
General procedure for the opening and C-1 alkylation of
substrates 1, 10 and 13
A solution of TiCl4 (1.0 mol equiv.; 2.0 in CH2Cl2) was added
to a solution of the substrate (0.40 mmol; 0.2 in CH2Cl2) at
Ϫ72 ЊC. After a certain time delay (see Table 1) the alkyl donor
was added dropwise and the solution was stirred for the time
and at the temperature indicated in Table 1. The progress of the
reaction was monitored by TLC (E/H 2:1). The reaction mix-
ture was quenched by slow addition into a vigorously stirred
cold water–ethyl acetate mixture (30:70). Stirring was con-
tinued for 1 h. The aqueous phase was extracted with ethyl
acetate, and the combined organic phases were washed with
water, dried (Na2SO4), and gently concentrated at reduced
pressure (12 mmHg; water bath ≈35 ЊC).
(2R,3S,5R)- and (2R,3S,5S)-1,3,5-Trimethoxyhexan-2-ol 2
and 3 (entries 1–6). The general procedure was applied to
compound 1 and the methyl-group donors shown in Table 1.
Column chromatography (E/H 1:10 → 1:1) of the crude
product gave an inseparable mixture of products 2/3 as a syrup:
ν(film)/cmϪ1 3420; δH 3.86 and 3.74 (each 1 H, 2 m), 3.50 (6 H,
m), 3.42, 3.40, 3.34, 3.33, 3.32 and 3.32 (each 3 H, 6 s), 2.59
(each 1 H, 2 s), 1.88 and 1.85 (each 1 H, 2 m), 1.67 and 1.58
(each 2 H, 2 m) and 1.17 and 1.16 (each 3 H, 2 d, J 6.3 and 6.4);
δC 79.0, 78.7, 73.8, 73.5, 73.4, 73.0, 71.6, 71.3, 59.2, 59.1, 58.4,
Compound 12: Rf 0.35: [α]2D0 ϩ13 (c 0.58, CHCl3); ν(film)/cmϪ1
3430; δH 4.02 (1 H, m), 3.56 (3 H, m), 3.54, 3.44, 3.42 and 3.38
(each 3 H, 4 s), 3.41 (1 H, m), 3.27 (1 H, dd, J 5.7 and 5.8), 3.05
(1 H, d, J 3.0) and 1.26 (3 H, d, J 6.4); δC 84.8, 81.6, 76.9,
74.0, 71.1, 61.3, 59.3, 59.2, 56.9 and 15.7; HRMS (CI-CH4):
C10H23O5 (M ϩ H); Found: m/z, 223.1545.
(2R,3S,4S,5R)- and (2R,3S,4S,5S)-1,3,4,5-Tetramethoxy-
hexan-2-ol 14 and 15 (entries 18–21). The general procedure was
applied to anomeric glycosides α-13 and β-13, respectively,
and the alkyl donors shown in Table 1. Column chrom-
atography (E/H 1:10 → 1:1) of the crude product gave
compound 15 or
a mixture of diastereomers 14/15 as
syrups.
Compound 15: [α]2D0 Ϫ9 (c 2.30, CHCl3); ν(film)/cmϪ1 3450; δH
3.88 (1 H, m), 3.60–3.44 (4 H, m), 3.53, 3.51, 3.38 and 3.32
(each 3 H, 4 s), 3.30 (1 H, m), 2.79 (1 H, d, J 5.2) and 1.24 (3 H,
d, J 6.3); δC 84.7, 81.1, 75.9, 74.1, 69.9, 61.0, 60.9, 59.2, 56.6
and 14.8; HRMS (CI-CH4): C10H23O5 (M ϩ H); Found: m/z,
223.1544.
788
J. Chem. Soc., Perkin Trans. 1, 1998